Rapid Micro Biosystems (NASDAQ:RPID) CFO Sean Wirtjes Sells 6,027 Shares

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CFO Sean Wirtjes sold 6,027 shares of Rapid Micro Biosystems stock in a transaction dated Monday, February 9th. The shares were sold at an average price of $3.78, for a total value of $22,782.06. Following the transaction, the chief financial officer directly owned 483,928 shares of the company’s stock, valued at $1,829,247.84. The trade was a 1.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Rapid Micro Biosystems Trading Up 8.8%

Shares of Rapid Micro Biosystems stock opened at $4.08 on Wednesday. Rapid Micro Biosystems, Inc. has a 12-month low of $1.86 and a 12-month high of $4.94. The company has a market cap of $180.83 million, a price-to-earnings ratio of -4.04 and a beta of 1.38. The company has a current ratio of 4.23, a quick ratio of 2.95 and a debt-to-equity ratio of 0.42. The company’s 50-day moving average price is $3.66 and its 200-day moving average price is $3.39.

Institutional Trading of Rapid Micro Biosystems

A number of hedge funds have recently made changes to their positions in RPID. Geode Capital Management LLC grew its position in Rapid Micro Biosystems by 1.6% during the 2nd quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock worth $704,000 after acquiring an additional 3,143 shares during the last quarter. Evernest Financial Advisors LLC lifted its position in Rapid Micro Biosystems by 355.1% in the third quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company’s stock valued at $669,000 after purchasing an additional 156,234 shares during the last quarter. Hudson Bay Capital Management LP bought a new stake in Rapid Micro Biosystems in the third quarter valued at approximately $38,000. Nano Cap New Millennium Growth Fund L P purchased a new stake in shares of Rapid Micro Biosystems during the fourth quarter valued at approximately $72,000. Finally, XTX Topco Ltd bought a new position in shares of Rapid Micro Biosystems in the second quarter worth approximately $144,000. 52.60% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Thursday, January 22nd. Wall Street Zen downgraded Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a research report on Saturday, January 17th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $8.00.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.